These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2939135)

  • 21. Reaction of mast cell proteases tryptase and chymase with protease activated receptors (PARs) on keratinocytes and fibroblasts.
    Schechter NM; Brass LF; Lavker RM; Jensen PJ
    J Cell Physiol; 1998 Aug; 176(2):365-73. PubMed ID: 9648924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chymase-directed serine protease inhibitor that reacts with a single 30-kDa granzyme and blocks NK-mediated cytotoxicity.
    Woodard SL; Jackson DS; Abuelyaman AS; Powers JC; Winkler U; Hudig D
    J Immunol; 1994 Dec; 153(11):5016-25. PubMed ID: 7963562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Granule-associated serine neutral proteases of the mouse bone marrow-derived mast cell that degrade fibronectin: their increase after sodium butyrate treatment of the cells.
    DuBuske L; Austen KF; Czop J; Stevens RL
    J Immunol; 1984 Sep; 133(3):1535-41. PubMed ID: 6205085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An analysis of the relationship between 5-lipoxygenase product generation and the secretion of preformed mediators from mouse bone marrow-derived mast cells.
    Razin E; Romeo LC; Krilis S; Liu FT; Lewis RA; Corey EJ; Austen KF
    J Immunol; 1984 Aug; 133(2):938-45. PubMed ID: 6330206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of enzymatic activity of human mast cell tryptase and chymase by protease inhibitors.
    He SH; Chen P; Chen HQ
    Acta Pharmacol Sin; 2003 Sep; 24(9):923-9. PubMed ID: 12956943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 2.2 A crystal structure of human chymase in complex with succinyl-Ala-Ala-Pro-Phe-chloromethylketone: structural explanation for its dipeptidyl carboxypeptidase specificity.
    Pereira PJ; Wang ZM; Rubin H; Huber R; Bode W; Schechter NM; Strobl S
    J Mol Biol; 1999 Feb; 286(1):163-73. PubMed ID: 9931257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chymase: a new pharmacologic target in cardiovascular disease.
    Bacani C; Frishman WH
    Cardiol Rev; 2006; 14(4):187-93. PubMed ID: 16788331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification and characterization of lymphocyte chymase I, a granzyme implicated in perforin-mediated lysis.
    Woodard SL; Fraser SA; Winkler U; Jackson DS; Kam CM; Powers JC; Hudig D
    J Immunol; 1998 May; 160(10):4988-93. PubMed ID: 9590247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of rat mast cell protease 1 activity. Protease inhibition is prevented by heparin proteoglycan.
    Pejler G; Berg L
    Eur J Biochem; 1995 Oct; 233(1):192-9. PubMed ID: 7588746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of tryptase and chymase induced nucleated cell infiltration by proteinase inhibitors.
    He SH; Chen HQ; Zheng J
    Acta Pharmacol Sin; 2004 Dec; 25(12):1677-84. PubMed ID: 15569415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetic studies on the inhibitions of mast cell chymase by natural serine protease inhibitors: indications for potential biological functions of these inhibitors.
    Fukusen N; Kato Y; Kido H; Katunuma N
    Biochem Med Metab Biol; 1987 Oct; 38(2):165-9. PubMed ID: 3479119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chymase bound to heparin is resistant to its natural inhibitors and capable of proteolyzing high density lipoproteins in aortic intimal fluid.
    Lindstedt L; Lee M; Kovanen PT
    Atherosclerosis; 2001 Mar; 155(1):87-97. PubMed ID: 11223430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mast cell proteoglycans modulate the secretagogue, proteoglycanase, and amidolytic activities of dog mast cell chymase.
    Sommerhoff CP; Ruoss SJ; Caughey GH
    J Immunol; 1992 May; 148(9):2859-66. PubMed ID: 1573274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of rat serosal mast cell biochemistry by in vivo dexamethasone administration.
    Marquardt DL; Wasserman SI
    J Immunol; 1983 Aug; 131(2):934-9. PubMed ID: 6306110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adriamycin induces exocytosis in rat and beige mouse peritoneal mast cells: an ultrastructural, morphometric and biochemical study.
    Crivellato E; Candussio L; Decorti G; Klugmann FB; Mallardi F
    J Submicrosc Cytol Pathol; 1999 Apr; 31(2):279-86. PubMed ID: 10457614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human mast cell chymase induces the accumulation of neutrophils, eosinophils and other inflammatory cells in vivo.
    He S; Walls AF
    Br J Pharmacol; 1998 Dec; 125(7):1491-500. PubMed ID: 9884078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chymotrypsin- and trypsin-type serine proteases in rat mast cells: properties and functions.
    Kido H; Fukusen N; Katunuma N
    Arch Biochem Biophys; 1985 Jun; 239(2):436-43. PubMed ID: 3890754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations in mast cell proteinases and protease inhibitors in the progress of cutaneous herpes zoster infection.
    Kaminska R; Harvima IT; Naukkarinen A; Nilsson G; Horsmanheimo M
    J Pathol; 1996 Dec; 180(4):434-40. PubMed ID: 9014866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mast cell expression of gelatinases A and B is regulated by kit ligand and TGF-beta.
    Fang KC; Wolters PJ; Steinhoff M; Bidgol A; Blount JL; Caughey GH
    J Immunol; 1999 May; 162(9):5528-35. PubMed ID: 10228034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of histamine release from cultured human mast cells.
    Igarashi Y; Kurosawa M; Ishikawa O; Miyachi Y; Saito H; Ebisawa M; Iikura Y; Yanagida M; Uzumaki H; Nakahata T
    Clin Exp Allergy; 1996 May; 26(5):597-602. PubMed ID: 8735874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.